Cognition Therapeutics, Inc.
CGTX
$0.3724
-$0.0008-0.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.67% | -47.24% | -48.98% | -48.27% | -57.10% |
| Total Depreciation and Amortization | 7.58% | 7.69% | 9.84% | -3.33% | 10.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.14% | -16.34% | 11.90% | -9.24% | 18.74% |
| Change in Net Operating Assets | -173.97% | 46.01% | -203.57% | -74.61% | 125.96% |
| Cash from Operations | -53.63% | -64.65% | -62.26% | -167.80% | 46.43% |
| Capital Expenditure | 96.67% | 100.00% | 83.33% | -- | -200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 96.67% | 100.00% | 83.33% | -- | -200.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.94% | 13.95% | 13.81% | 14.01% | 12.68% |
| Issuance of Common Stock | 392.93% | 142.45% | -97.18% | 6,131.98% | -51.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 366.63% | 11,066.67% | -106.59% | 120,030.00% | -52.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 198.39% | -54.51% | -278.89% | 272.57% | 39.64% |